Related Experiment Video

Updated: Jun 1, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

Published on: July 28, 2020

Metastatic soft tissue sarcoma chemotherapy: an opportunity for personalized medicine

Damon Reed1, Soner Altiok

  • 1Department of Sarcoma at The H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA. Damon.Reed@moffitt.org

Cancer Control : Journal of the Moffitt Cancer Center
|June 14, 2011
PubMed
Abstract

Insights

Developing predictive tests for soft tissue sarcoma (STS) chemotherapy response is crucial. Currently, clinical features guide STS treatment, but validated predictive tests are lacking, highlighting a need for improved strategies.

Area of Science:

  • Oncology
  • Medical Research

Background:

  • Soft tissue sarcoma (STS) encompasses diverse mesenchymal tumors.
  • STS exhibits relative chemotherapy resistance compared to other sarcoma types.

Purpose of the Study:

  • To review literature for predictive strategies in STS chemotherapy decision-making.
  • To address clinical challenges faced by oncologists in treating STS.

Main Methods:

  • Literature review on predictive strategies for chemotherapy in STS.
  • Discussion of clinical challenges in STS management.

Main Results:

  • No validated predictive tests currently exist for STS chemotherapeutic response or resistance.
  • Histology, stage, and patient age are primary factors guiding STS therapy.

Conclusions:

  • A predictive method for chemotherapy response in STS is needed.
  • Such a method would reduce toxicity and improve response rates for STS patients.
  • Predictive tools are essential for designing future STS clinical trials.

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...